Cross-sectional study compares MRI-detected hepatic iron deposition in chronic liver disease and healthy controls, suggesting enhanced diagnostic capabilities.
Key Points
Chronic liver disease patients show higher hepatic iron deposition and disruptions in iron metabolism compared to healthy controls.
CLD patients had significant differences in serum ferritin levels (149.35 vs. 213.48 ng/mL) and R² values (57.82 vs. 76.43), indicating increased iron overload.
MRI techniques, including R² mapping and structured grading, were employed to assess liver iron content non-invasively, providing critical insights.
These findings support MRI as a superior method for detecting early hepatic iron accumulation over traditional serum biomarkers.